Compile Data Set for Download or QSAR
Report error Found 348 Enz. Inhib. hit(s) with Target = 'Fusion glycoprotein F0'
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50541849(Presatovir | GS-5806)
Affinity DataEC50:  0.100nMAssay Description:Inhibition of Human respiratory syncytial virus A2 Fusion protein expressed in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542668(CHEMBL4645289)
Affinity DataEC50:  0.100nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50450579(JNJ 2408068 | JNJ-240806 | JNJ-2408068 | R-170591)
Affinity DataEC50:  0.160nMAssay Description:Inhibition of RSV Long fusion protein assessed as decrease in virus induced syncytium formation in infected human HeLa/M cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542631(CHEMBL4633144)
Affinity DataEC50:  0.200nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542663(CHEMBL4647497)
Affinity DataEC50:  0.200nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542624(CHEMBL4639647)
Affinity DataEC50:  0.200nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542633(CHEMBL4642009)
Affinity DataEC50:  0.251nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542648(CHEMBL4644121)
Affinity DataEC50:  0.251nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542647(CHEMBL4644338)
Affinity DataEC50:  0.251nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542667(CHEMBL4635306)
Affinity DataEC50:  0.251nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554856(CHEMBL4740044)
Affinity DataEC50:  0.270nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542665(CHEMBL4639685)
Affinity DataEC50:  0.316nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542675(CHEMBL4644767)
Affinity DataEC50:  0.316nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554858(CHEMBL4750881)
Affinity DataEC50:  0.330nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542626(CHEMBL4637901)
Affinity DataEC50:  0.398nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542653(CHEMBL4634123)
Affinity DataEC50:  0.398nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572440(CHEMBL4469438)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554876(CHEMBL4747540)
Affinity DataEC50:  0.470nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572444(CHEMBL4878302)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542646(CHEMBL4648807)
Affinity DataEC50:  0.501nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542662(CHEMBL4639834)
Affinity DataEC50:  0.501nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542661(CHEMBL4646241)
Affinity DataEC50:  0.501nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542657(Rilematovir | Jnj-53718678)
Affinity DataEC50:  0.501nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542651(CHEMBL4636246)
Affinity DataEC50:  0.501nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542666(CHEMBL4632978)
Affinity DataEC50:  0.631nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554877(CHEMBL4755451)
Affinity DataEC50:  0.640nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50541842(CHEMBL4647328)
Affinity DataEC50:  0.660nMAssay Description:Inhibition of Human respiratory syncytial virus A2 Fusion protein expressed in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572466(CHEMBL4876200)
Affinity DataIC50: 0.690nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572442(CHEMBL4872095)
Affinity DataIC50: 0.700nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554856(CHEMBL4740044)
Affinity DataEC50:  0.700nMAssay Description:Inhibition of F protein D486N mutant in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554874(CHEMBL4746199)
Affinity DataEC50:  0.740nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554875(CHEMBL4765002)
Affinity DataEC50:  0.770nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542632(CHEMBL4640078)
Affinity DataEC50:  0.794nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50286846(CHEMBL4169507)
Affinity DataEC50:  0.800nMAssay Description:Inhibition of RSV long strain fusion protein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect after 5 days by CCK8 ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/21/2020
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554864(CHEMBL4747375)
Affinity DataEC50:  0.810nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554859(CHEMBL4747256)
Affinity DataEC50:  0.870nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572463(CHEMBL4871101)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572464(CHEMBL4858040)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572450(Sisunatovir | Rv-521 | Rv521)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50277049(CHEMBL4169195)
Affinity DataEC50:  1nMAssay Description:Inhibition of Respiratory syncytial virus Long fusion glycoprotein infected in Hep2 cells assessed as reduction in virus-induced cytopathic effect af...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/28/2020
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50450572(CHEMBL4164975)
Affinity DataEC50:  1nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542645(CHEMBL4639912)
Affinity DataEC50:  1nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542644(CHEMBL4633557)
Affinity DataEC50:  1nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542643(CHEMBL4641189)
Affinity DataEC50:  1nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572451(CHEMBL4867108)
Affinity DataIC50: 1nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50542669(CHEMBL4646649)
Affinity DataEC50:  1nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554873(CHEMBL4752524)
Affinity DataEC50:  1.10nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554872(CHEMBL4751254)
Affinity DataEC50:  1.10nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572465(CHEMBL4858949)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572445(CHEMBL4865906)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
Displayed 1 to 50 (of 348 total ) | Next | Last >>
Jump to: